Showing 917 results
-
Press release /Latest in HR+/HER2- metastatic breast cancer, including data on CDK recycling with Kisqali® plus endocrine therapy, further MONALEESA-2 quality of life and overall survival analyses, and a new…
-
Press release /BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated HR+/HER2- advanced breast cancer after progression on an aromatase inhibitor…
-
Story /Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.
-
Story /Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.
-
Biography /
-
Story /Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
-
Story /For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.
-
Press release /Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination with oral endocrine therapy compared to oral endocrine therapy in pre- or perimenopausal…
Pagination
- ‹ Previous page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- …
- 92
- › Next page